Literature DB >> 22285861

Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.

Zheng Guo1, Yuning Zhou, B Mark Evers, Qingding Wang.   

Abstract

Rictor (Rapamycin-insensitive companion of mTOR) forms a complex with mTOR and phosphorylates and activates Akt. Activation of Akt induces expression of c-Myc and cyclin E, which are overexpressed in colorectal cancer and play an important role in colorectal cancer cell proliferation. Here, we show that rictor associates with FBXW7 to form an E3 complex participating in the regulation of c-Myc and cyclin E degradation. The Rictor-FBXW7 complex is biochemically distinct from the previously reported mTORC2 and can be immunoprecipitated independently of mTORC2. Moreover, knocking down of rictor in serum-deprived colorectal cancer cells results in the decreased ubiquitination and increased protein levels of c-Myc and cyclin E while overexpression of rictor induces the degradation of c-Myc and cyclin E proteins. Genetic knockout of FBXW7 blunts the effects of rictor, suggesting that rictor regulation of c-Myc and cyclin E requires FBXW7. Our findings identify rictor as an important component of FBXW7 E3 ligase complex participating in the regulation of c-Myc and cyclin E protein ubiquitination and degradation. Importantly, our results suggest that elevated growth factor signaling may contribute to decrease rictor/FBXW7-mediated ubiquitination of c-Myc and cyclin E, thus leading to accumulation of cyclin E and c-Myc in colorectal cancer cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285861      PMCID: PMC3278531          DOI: 10.1016/j.bbrc.2012.01.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

2.  Phosphorylation of Rictor at Thr1135 impairs the Rictor/Cullin-1 complex to ubiquitinate SGK1.

Authors:  Daming Gao; Lixin Wan; Wenyi Wei
Journal:  Protein Cell       Date:  2010-10       Impact factor: 14.870

3.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

4.  Genetic Control of the Cell Division Cycle in Yeast: V. Genetic Analysis of cdc Mutants.

Authors:  L H Hartwell; R K Mortimer; J Culotti; M Culotti
Journal:  Genetics       Date:  1973-06       Impact factor: 4.562

Review 5.  Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Authors:  Jiyong Liang; Joyce M Slingerland
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

Review 6.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.

Authors:  Markus Welcker; Bruce E Clurman
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

Review 7.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

8.  Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma.

Authors:  Thomas Sutter; Temuujin Dansranjavin; Jan Lubinski; Tadeusz Debniak; Joannis Giannakudis; Cuong Hoang-Vu; Henning Dralle
Journal:  Int J Colorectal Dis       Date:  2002-03-08       Impact factor: 2.571

9.  hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.

Authors:  Takashi Kimura; Mitsukazu Gotoh; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Cancer Sci       Date:  2003-05       Impact factor: 6.716

Review 10.  Wnt/Myc interactions in intestinal cancer: partners in crime.

Authors:  Kevin Myant; Owen J Sansom
Journal:  Exp Cell Res       Date:  2011-08-07       Impact factor: 3.905

View more
  21 in total

1.  Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.

Authors:  Jian-Xin Jiang; Cheng-Yi Sun; She Tian; Chao Yu; Mei-Yuan Chen; Hao Zhang
Journal:  Tumour Biol       Date:  2016-08-03

2.  Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.

Authors:  Junghui Koo; Xiaoyun Wu; Zixu Mao; Fadlo R Khuri; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

Review 3.  DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors:  Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

4.  Rictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation.

Authors:  Daniel Smrz; Glenn Cruse; Michael A Beaven; Arnold Kirshenbaum; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

5.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

6.  mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.

Authors:  Junghui Koo; Ping Yue; Xingming Deng; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

7.  Rictor is an independent prognostic factor for endometrial carcinoma.

Authors:  Shan-Yun Wen; Chang-Hua Li; Yan-Li Zhang; Yu-Hai Bian; Li Ma; Qiu-Lin Ge; Yin-Cheng Teng; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 8.  Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.

Authors:  Ka Wai Mok; Dolores D Mruk; C Yan Cheng
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 9.  Physiological functions of FBW7 in cancer and metabolism.

Authors:  Kouhei Shimizu; Naoe Taira Nihira; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Cell Signal       Date:  2018-02-21       Impact factor: 4.315

10.  In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI-2 and dinaciclib.

Authors:  Mary Ellen Urick; Daphne W Bell
Journal:  Mol Carcinog       Date:  2018-07-12       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.